Psilocybin

The global psychedelic market continues to attract attention from researchers, healthcare organizations, investors, service providers, and technology companies. One commercial forecast valued the psychedelic drugs market at $7.4 billion in 2025 and projected it could reach $22.6 billion by 2033, representing a compound annual growth rate of approximately 15%. However, market estimates vary considerably depending […]

Research into psychedelic and cannabis treatments is changing how scientists approach depression, post-traumatic stress disorder, chronic pain, and other difficult-to-treat conditions. Psilocybin, MDMA, cannabis, and individual cannabinoids have all produced promising findings. However, promising research does not necessarily mean a treatment is proven, approved, or appropriate for unsupervised use. As of August 2026, neither psilocybin […]

Psilocybin payment processing can be hard to secure. The main reason is simple: state and federal laws do not match. Oregon and Colorado allow certain psilocybin services through regulated programs. However, psilocybin remains a Schedule I controlled substance under federal law. As a result, many banks and payment companies will not support the industry. Still, […]

Functional mushrooms have moved from traditional wellness practices into mainstream products. Lion’s mane coffee, reishi capsules, cordyceps powders, and mushroom gummies are now widely available online and in health-focused stores. Interest in these products continues to grow. However, the research supporting many functional mushroom claims is still developing. Some mushrooms contain potentially useful compounds, but […]

The future of health care could be psychedelic. As the stigma surrounding psychedelic substances continues to fade, these substances are increasingly being recognized for their potential in treating a range of mental health disorders. This article explores the future of psychedelic treatment centers in America, with a particular focus on payment processing for such facilities. […]

Psychedelics, once dubbed as rebel party stimulants, are now emerging as a transformative crucible for mental health treatment. In particular, psilocybin and ketamine, two potent psychedelic substances, are making significant strides in the therapeutic arena. With the burgeoning acceptance of these substances in therapy, we are witnessing the emergence of psilocybin payments and ketamine payments […]

In the fascinating realm of mycology, the study of fungi, one particular subject of interest has been steadily gaining attention – Psilocybin spores. These minuscule, single-celled reproductive units are the genesis of the widely renowned psychedelic mushrooms. This article provides an in-depth exploration of psilocybin spores, their legalities, cultivation, availability, and more, with a special […]